VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 70 filers reported holding VERASTEM INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $229 | -47.4% | 552,329 | -48.9% | 0.00% | – |
Q4 2022 | $435 | -100.0% | 1,081,342 | -66.4% | 0.00% | -100.0% |
Q3 2022 | $2,739,000 | -54.2% | 3,222,292 | -37.5% | 0.00% | -50.0% |
Q2 2022 | $5,979,000 | +325.6% | 5,154,530 | +417.3% | 0.00% | +300.0% |
Q1 2022 | $1,405,000 | -52.8% | 996,422 | -31.3% | 0.00% | -50.0% |
Q4 2021 | $2,974,000 | -5.3% | 1,450,563 | +42.3% | 0.00% | 0.0% |
Q3 2021 | $3,139,000 | -45.0% | 1,019,015 | -27.3% | 0.00% | -33.3% |
Q2 2021 | $5,703,000 | +363.7% | 1,401,182 | +37.8% | 0.00% | +50.0% |
Q3 2020 | $1,230,000 | -68.0% | 1,016,838 | -54.6% | 0.00% | -60.0% |
Q2 2020 | $3,848,000 | +51.1% | 2,237,423 | +131.9% | 0.01% | -16.7% |
Q1 2020 | $2,547,000 | +4448.2% | 964,780 | +2196.1% | 0.01% | – |
Q4 2019 | $56,000 | -13.8% | 42,019 | -22.8% | 0.00% | – |
Q3 2019 | $65,000 | -97.6% | 54,409 | -97.0% | 0.00% | -100.0% |
Q2 2019 | $2,743,000 | +107.0% | 1,816,781 | +306.0% | 0.00% | +100.0% |
Q1 2019 | $1,325,000 | -68.4% | 447,528 | -64.1% | 0.00% | -71.4% |
Q4 2018 | $4,193,000 | +1048.8% | 1,248,037 | +2376.5% | 0.01% | – |
Q3 2018 | $365,000 | -69.3% | 50,395 | -70.9% | 0.00% | -100.0% |
Q2 2018 | $1,190,000 | +32.1% | 172,934 | -42.8% | 0.00% | +100.0% |
Q1 2018 | $901,000 | -17.9% | 302,218 | -15.5% | 0.00% | -50.0% |
Q4 2017 | $1,098,000 | +25.9% | 357,615 | +92.8% | 0.00% | +100.0% |
Q3 2017 | $872,000 | +1457.1% | 185,449 | +587.2% | 0.00% | – |
Q1 2017 | $56,000 | -56.6% | 26,986 | -76.5% | 0.00% | – |
Q4 2016 | $129,000 | -42.7% | 114,849 | -32.1% | 0.00% | – |
Q3 2016 | $225,000 | -40.2% | 169,169 | -41.5% | 0.00% | -100.0% |
Q2 2016 | $376,000 | +700.0% | 289,383 | +880.1% | 0.00% | – |
Q1 2016 | $47,000 | -95.2% | 29,525 | -94.4% | 0.00% | -100.0% |
Q4 2015 | $978,000 | +695.1% | 525,706 | +664.1% | 0.00% | – |
Q3 2015 | $123,000 | +18.3% | 68,797 | +399.8% | 0.00% | – |
Q2 2015 | $104,000 | -43.5% | 13,764 | -24.0% | 0.00% | – |
Q1 2015 | $184,000 | -79.6% | 18,121 | -81.6% | 0.00% | -100.0% |
Q4 2014 | $902,000 | +246.9% | 98,727 | +309.8% | 0.00% | +100.0% |
Q1 2014 | $260,000 | – | 24,090 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 2,951,000 | $4,161,000 | 1.39% |
MPM BioImpact LLC | 3,244,650 | $4,575,000 | 1.23% |
BVF INC/IL | 19,974,658 | $28,164,000 | 1.13% |
Opaleye Management Inc. | 2,325,000 | $3,278,000 | 1.02% |
ACUTA CAPITAL PARTNERS, LLC | 996,951 | $1,406,000 | 0.66% |
Telemetry Investments, L.L.C. | 135,000 | $190,000 | 0.30% |
Soleus Capital Management, L.P. | 1,644,500 | $2,319,000 | 0.30% |
Baker Brothers Advisors | 26,988,898 | $38,054,000 | 0.22% |
Ikarian Capital, LLC | 678,023 | $956,000 | 0.13% |
Samalin Investment Counsel, LLC | 124,000 | $175,000 | 0.11% |